Health Care · NYSE: CNC
Centene: how the business works
Centene runs health plans, mostly paid for by governments, for 27.6 million members, with total revenues of $194.8 billion in FY2025.
By Hardik Bhandare · Checked against filings: . Editorial policy. Corrections
Follow Centene
Email me when Centene's page is updated after earnings.
We'll send a confirmation email first. See our privacy policy.
Centene Corporation · St. Louis, Missouri · Founded 1984
Updated for Q3 FY2026 · checked
- Total revenues, FY2025
- $194.8B
- Net loss, FY2025
- $6.67B
- Members, Dec 31, 2025
- 27.6 million
- Health benefits ratio, FY2025
- 91.9%
- Employees, Sep 30, 2026
- 53,900
The short version
Centene in 5 points
1 · What it sells
Centene runs Medicaid, Medicare and Marketplace health plans for 27.6 million members at Dec 31, 2025, with total revenues of $194.8 billion in FY2025.
2 · Who pays it
In FY2025, Centene's Medicaid segment, paid by states, brought in 57% of external revenues, Commercial (mostly Marketplace plans) 21%, Medicare 19% and Other 3%.
3 · What it keeps from $100
Of every $100 that came in during FY2025, Centene spent $80.32 on medical bills and lost $3.40 after $7,311 million of impairment charges; adjusted net earnings, a non-GAAPThe company's own "adjusted" numbers, not the official (GAAP) ones. Always read them next to the official figure. Learn more measure, were $1,028 million.
4 · Where the operating profit comes from
FY2025 gross margin (premium and service revenues less medical and service costs) was $5,690 million in Medicaid, $5,101 million in Commercial, $2,983 million in Medicare and $435 million in Other.
5 · The one thing to watch
The health benefits ratio was 92.7% in Q3 FY2026; on Oct 27, 2026, Centene said it expects 90.4% to 91.1% for full-year 2026.
Sources: From Centene's FY2025 10-K and its Q3 FY2026 earnings release · checked
01Where $100 of an insurer's money goes · FY2025
Where does $100 of Centene's money go?
Centene · FY2025
Receipt for every $100
| Members' medical bills (medical costs) | $80.3 |
|---|---|
| Premium taxes paid to states | $10.5 |
| Running costs (SG&A and cost of services) | $7.9 |
| Impairment charges (mostly goodwill) | $3.7 |
| Depreciation, amortization and interest | $1.0 |
| Income tax (a benefit) | −$0.0 |
| Net loss | −$3.4 |
| Total | $100 |
Each line = amount ÷ total money in × 100. Lines may not add to exactly $100 because of rounding.
How this is worked out
Cityfort calculation from the FY2025 10-K: each line ÷ $196,349 million of money in (total revenues of $194,777 million plus $1,572 million of investment and other income) × 100. The net loss line includes $7,311 million of impairment charges.
Save this receipt as an image
Embed this receipt or the key numbers
Paste this code into a blog or website to show the card you choose, with a link back to this page.
Each week: the next company due to report earnings, explained in 5 points.
No tips. Unsubscribe anytime.
We'll send a confirmation email. See our privacy policy.
02The business in one line
What does Centene do?
States, the federal government and members pay Centene premiums; members' medical bills took 91.9% of those premiums in FY2025.
- Centene's Medicaid segment, paid by states, brought in 57% of external revenues in FY2025, Commercial 21% and Medicare 19%.
- Of every $100 that came in during FY2025, medical bills took $80.32 and premium taxes $10.46; impairment charges turned the year into a $3.40 loss.
03Who pays it
Who pays Centene?
State Medicaid agencies
57%
of revenue
States pay a monthly premium per Medicaid member under multi-year contracts that are re-bid.
Marketplace members and federal subsidies
21%
of revenue
Individuals buy Ambetter Health plans; the federal government pays part of many premiums through tax credits.
Medicare program and its members
19%
of revenue
The federal Centers for Medicare and Medicaid Services (CMS) pays for Medicare Advantage and drug plans, with members paying part of some premiums.
Other customers
3%
of revenue
Payers for specialty pharmacy, behavioral health, vision and dental services.
- State Medicaid agencies57%
- Marketplace members and federal subsidies21%
- Medicare program and its members19%
- Other customers3%
How spread out the customers are
No single customer was more than 10% of Centene's total revenues in 2023, 2024 or 2025. Most revenue comes from state Medicaid contracts, and Florida and New York were each about 10% or more of Medicaid premium revenues in 2025.
Sources (1)
04How it makes money
How does Centene make money?
Centene earns the gap between the premiums it collects and the medical bills it pays.
Premiums are set before the year starts, and members' bills come in later. Medical costs took 87.8% of premiums in FY2021 and 91.9% in FY2025, so a few points decide whether the year makes money.
Health benefits ratio (medical costs ÷ premiums)
87.8%91.9%
FY2021 to FY2025
- States, the federal government and members pay a premium for each member.
- Centene pays doctors, hospitals and pharmacies for members' care.
- Selling and administrative costs were 7.4% of premium and service revenues in FY2025 (Centene's SG&A expense ratio).
- Money waiting to pay claims is invested and earns income.
- Prices and benefits are reset for the next year, based on how costs ran.
↺ Step 5 feeds back into step 1.
05Business segments · FY2025
Which businesses make up Centene?
Medicaid
56.7%State Medicaid plans. Gross margin (premium and service revenues less medical and service costs) was $5,690 million in FY2025.
Revenue $110.4B ($110,434M)
Commercial
21.6%Marketplace and other individual and group plans. Gross margin was $5,101 million in FY2025, down from $7,663 million in FY2024.
Revenue $42.0B ($42,003M)
Medicare
19.1%Medicare Advantage, drug plans and Medicare Supplement. Gross margin was $2,983 million in FY2025.
Revenue $37.2B ($37,210M)
Other
2.6%Specialty pharmacy, behavioral health, vision, dental and primary care. Gross margin was $435 million in FY2025.
Revenue $5.1B ($5,130M)
How the mix changed
- Medicaid
- Commercial
- Medicare
- Other
Revenue by segment, FY2022 to FY2025.
US$
See the numbers
06The numbers · Consolidated · US$
How has Centene done?
Premiums
$171.6BFY2025
Premium revenue rose every year, from $112,319 million in FY2021 to $171,556 million in FY2025, and was $44,370 million in Q3 FY2026, up from $44,126 million a year earlier.
US$ · premiums from policyholders and plan members, as reported
See the yearly numbers
See the quarterly numbers
Medical care ratio
91.9%FY2025
The health benefits ratio, the share of premiums spent on members' medical care, was 87.7% to 87.8% from FY2021 to FY2023, rose to 91.9% in FY2025 and was 92.7% in Q3 FY2026.
Centene calls its medical care ratio the health benefits ratio (HBR): medical costs ÷ premium revenue, leaving out service revenue and premium tax revenue.
% of premiums · medical costs per $100 of premiums, as reported
See the yearly numbers
See the quarterly numbers
Net income
−$6.7BFY2025
Net income was $3,305 million in FY2024 and a $6,674 million loss in FY2025, which included $7,311 million of impairment charges; investment and other income was $1,572 million in FY2025.
US$ · after claims, costs, investment results and tax; the table shows where it came from
See the numbers
See all yearly numbers
Medical care ratio = medical costs ÷ premiums, as the company reports it. Net investment income is interest and dividends on the money the company holds before paying claims; realized and unrealized gains are shown apart because they move with markets. Net income is the amount for common stockholders. Fiscal years are the company's own (December 31. Centene's fiscal year matches the calendar year: FY2025 ended Dec 31, 2025, and Q3 FY2026 ended Sep 30, 2026.).
- Revenue on this page is Centene's total revenues, which include state premium taxes it collects and pays on ($20,196 million in FY2025); premium and service revenues were $174,581 million.
- Fees and other is service revenue plus premium tax revenue. Investment income sits in one line with other income, below total revenues in Centene's statements, so premiums, fees and investment income add up to about 1% more than total revenues. Centene reports no separate realized or unrealized gains lines.
- Members are total members at year end, as reported; up to FY2024 they include 2.7 million to 2.9 million TRICARE military health eligibles, under a contract that ended in December 2024. In 2026 Centene moved some members eligible for both Medicaid and Medicare from its Medicaid to its Medicare tables.
- Underwriting expenses are selling, general and administrative expenses (SG&A). Book value per share and return on equity are not shown because Centene does not report them.
Learn: How to read a US earnings release: Nvidia's Q2 fiscal 2027 · What is return on equity? Profit on equity, with real US companies
Sources (14)
- Form 10-K for FY2023
- Form 10-K for FY2021
- Form 10-K for FY2022
- Form 10-K for FY2025
- Form 10-K for FY2024
- Earnings release for Q1 FY2025 (8-K Ex. 99.1)
- Earnings release for Q2 FY2025 (8-K Ex. 99.1)
- Earnings release for Q3 FY2024 (8-K Ex. 99.1)
- Earnings release for Q4 FY2024 (8-K Ex. 99.1)
- Earnings release for Q3 FY2025 (8-K Ex. 99.1)
- Earnings release for Q4 FY2025 (8-K Ex. 99.1)
- Earnings release for Q1 FY2026 (8-K Ex. 99.1)
- Earnings release for Q2 FY2026 (8-K Ex. 99.1)
- Earnings release for Q3 FY2026 (8-K Ex. 99.1)
07Who runs it
Who runs Centene, and did they deliver?
Sarah M. London
Chief Executive Officer · since 2022
CEO since March 2022.
Andrew L. Asher
Executive Vice President and Chief Financial Officer · since 2021
CFO since May 2021; earlier CFO of WellCare from 2014 to 2020.
Susan R. Smith
Chief Operating Officer
Frederick H. Eppinger
Independent Chairman of the board · since 2006
Director since 2006; the chair has been separate from the CEO since Mar 22, 2022.
What they said, and what happened
1 too early to tell · 1 delivered
Said on Feb 6, 2026
Full-year 2026 adjusted diluted EPS (a non-GAAP measure) above $3.00.
Too early to tellWhat happened
Centene raised it to above $3.40 on Apr 28, above $4.80 on Jul 28 and above $5.20 on Oct 27, 2026; adjusted diluted EPS was $6.45 for the first nine months.
Said on Oct 8, 2026
Redeem the remaining 4.25% senior notes due 2027 on Oct 23, 2026.
DeliveredWhat happened
The Q3 FY2026 earnings release says the 2027 notes were fully redeemed in October.
Sources (7)
08What could go wrong
What could go wrong for Centene?
- Pricing
Medical costs above what was priced
Centene sets premiums before the year starts. Medical costs took 87.7% of premiums in FY2023, 91.9% in FY2025 and 92.7% in Q3 FY2026.
Watch The health benefits ratio each quarter, against the 90.4% to 91.1% range Centene gave for 2026 on Oct 27, 2026.
- Regulation
Changes to government health programs
Extra federal Marketplace subsidies ended after 2025. A July 2025 federal law adds Medicaid work requirements and more frequent eligibility checks, largely from 2027. Marketplace members fell from 5.54 million at Dec 31, 2025 to 3.40 million at Sep 30, 2026.
Watch Marketplace and Medicaid membership each quarter.
- Concentration
Losing or re-bidding state contracts
Most revenue comes from state Medicaid contracts that are re-bid, and Florida and New York were each about 10% or more of Medicaid premium revenues in 2025. From Jan 1, 2027, about 175,000 Health Net members in California move to fee-for-service Medi-Cal.
Watch State contract awards, renewals and losses in 8-Ks and earnings releases.
- Regulation
Risk-adjustment estimates
Marketplace insurers pay into or receive from a federal risk-adjustment pool, settled after the year ends. In June 2026, CMS's final 2025 figures cut Centene's net payable by $541 million.
Watch Changes to risk-adjustment estimates in each 10-Q.
- Legal
Shareholder lawsuits
The Q3 FY2026 10-Q says a proposed class action filed on Jul 9, 2025 alleges false and misleading statements about Centene's 2025 earnings guidance, and five derivative suits followed. Centene denies wrongdoing; the 10-Q says an adverse outcome could have a material impact.
Watch Court rulings or settlements disclosed in 10-Qs.
- Debt
Debt and cash held in regulated units
Total debt was $15,542 million at Sep 30, 2026. Most cash sits in state-regulated subsidiaries; $175 million was available for general corporate use.
Watch Debt to capitalization (41.1% at Sep 30, 2026) and dividends from subsidiaries to the parent.
09Supporters vs. critics
What do supporters and critics point to?
What supporters point to
- Centene says it is the largest Medicaid and Marketplace insurer and the largest stand-alone Medicare drug plan provider by membership.
- Net income was $1,541 million in Q1 FY2026 and $1,091 million in Q2 FY2026, after losses in the last three quarters of FY2025.
- Medicare drug plan members grew from 6.93 million at Dec 31, 2024 to 8.95 million at Sep 30, 2026.
- Centene raised its 2026 adjusted diluted EPS guidance (a non-GAAP measure) three times, from above $3.00 on Feb 6 to above $5.20 on Oct 27, 2026.
- Centene says its regulated subsidiaries had $19.7 billion of statutory capital and surplus at Dec 31, 2025, against an $11.3 billion minimum.
What critics point to
- Medical costs took 87.7% of premiums in FY2023, 91.9% in FY2025 and 92.7% in Q3 FY2026.
- FY2025 ended with a $6,674 million net loss, which included $7,311 million of impairment charges.
- Marketplace members fell from 5.54 million at Dec 31, 2025 to 3.40 million at Sep 30, 2026.
- A proposed securities class action filed on Jul 9, 2025 alleges that Centene made false and misleading statements, and five derivative suits followed; Centene denies wrongdoing.
- Total debt was $15,542 million at Sep 30, 2026, and $175 million of cash was available for general corporate use.
10What to watch next
What should you watch next at Centene?
Next event
Q4 and full-year FY2026 results
Date not announced yet.
The health benefits ratio
It was 92.7% in Q3 FY2026. On Oct 27, 2026, Centene said it expects 90.4% to 91.1% for full-year 2026.
FY2026 results against guidance
On Oct 27, 2026, Centene said it expects 2026 GAAP diluted EPS above $3.46 and adjusted diluted EPS, a non-GAAP measure, above $5.20.
Marketplace and Medicaid members
Marketplace had 3.40 million members and Medicaid 11.90 million at Sep 30, 2026, both lower than at Dec 31, 2025.
Contracts and lawsuits
About 175,000 California Health Net members move to fee-for-service Medi-Cal from Jan 1, 2027. The shareholder suits are updated in each 10-Q.
11Key facts
Key facts about Centene
- What does Centene do?
- Centene Corporation, based in St. Louis, Missouri, runs health plans mostly paid for by governments. It runs Medicaid plans in 30 states, Medicare Advantage and drug plans, and Ambetter Health plans on the Affordable Care Act Marketplace. Centene had 27.6 million members at Dec 31, 2025.
- How does Centene make money?
- Centene collects a premium for each member and pays doctors, hospitals and pharmacies for the members' care. In FY2025, medical costs took 91.9% of Centene's $171,556 million of premium revenue, and selling and administrative costs were 7.4% of premium and service revenues (Centene's SG&A expense ratio).
- Who are Centene's customers?
- Centene's Medicaid segment, paid by state Medicaid agencies, brought in 57% of its external revenues in FY2025. Commercial, mostly Marketplace plans, brought in 21%, Medicare 19% and Other 3%. No single customer was more than 10% of Centene's total revenues in 2023, 2024 or 2025.
- How big is Centene?
- Centene had total revenues of $194,777 million in FY2025, up from $163,071 million in FY2024. Centene reported net income of $3,305 million in FY2024 and a net loss of $6,674 million in FY2025, which included $7,311 million of impairment charges.
- Why did Centene lose money in FY2025?
- Centene's FY2025 net loss of $6,674 million included $7,311 million of impairment charges, mostly a $6,723 million goodwill impairment. Goodwill is the amount paid for past acquisitions above the value of their assets. Medical costs also took 91.9% of premiums in FY2025, up from 88.3% in FY2024. Centene's adjusted net earnings, a non-GAAP measure that leaves out these charges, were $1,028 million in FY2025.
- How did Centene do in Q3 FY2026?
- Centene had total revenues of $50,647 million in Q3 FY2026 and a net loss of $71 million, against a $6,631 million loss in Q3 FY2025. Its health benefits ratio, medical costs as a share of premiums, was 92.7% in both quarters.
- How many members does Centene have?
- Centene's Marketplace members fell from 5.54 million at Dec 31, 2025 to 3.40 million at Sep 30, 2026. Its Medicaid members fell from 12.52 million to 11.90 million, and its Medicare drug plan members reached 8.95 million over the same period.
- Who runs Centene?
- Sarah London has been Centene's chief executive officer since March 2022, and Andrew Asher its chief financial officer since May 2021. Frederick Eppinger, a director since 2006, is Centene's independent chairman.
- Who owns Centene?
- Centene has one class of common stock, with 494.97 million shares outstanding at Sep 30, 2026. The 2026 proxy lists The Vanguard Group at 12.4%, BlackRock at 7.8% and AQR Capital Management at 6.5%, from filings of different dates. Centene's directors and executive officers together owned under 1% as of Mar 13, 2026.
Terms on this page
Each explains the term in plain English, with the same number from other companies on Cityfort.
Go deeper
More detail from the same filings. Open any section.
12What it sells
12What it sells
What does Centene sell?
Medicaid plans
Health coverage that states pay Centene to manage, including care for children, pregnant women, disabled adults and long-term care. 12.5 million members in 30 states at Dec 31, 2025.
Medicare Advantage (Wellcare)
Private plans that replace traditional Medicare for people 65 and over, including plans for people who also qualify for Medicaid. 1.0 million members in 32 states at Dec 31, 2025.
Medicare drug plans
Stand-alone prescription drug plans (PDP) for Medicare members, sold in all 50 states and DC. 8.1 million members at Dec 31, 2025.
Marketplace plans (Ambetter Health)
Individual health insurance bought on the Affordable Care Act exchanges, often with federal subsidies. 5.5 million members in 29 states at Dec 31, 2025.
Other services
A specialty pharmacy (AcariaHealth), vision and dental services, primary care centers in Florida and the Magellan Health behavioral health business, which Centene agreed to sell in December 2025.
What it does
- Does: Collects a monthly premium for each member from states, the federal government or the member
- Does: Pays doctors, hospitals and pharmacies for members' care
- Does: Collects state premium taxes and passes them on
What it does not do
- Does not: Does not run most of the hospitals and doctor offices its members use; it signs contracts with them
- Does not: Does not run its own pharmacy benefit manager; it has used an outside one since January 2024
- Does not: Has few employer plan members: individual and commercial group plans had 452,500 members at Dec 31, 2025
Sources (1)
13How the money flows
13How the money flows · FY2025
How does money flow through Centene?
Money in
- Premiums$171.6B
- Service revenue$3.0B
- Premium tax revenue (collected for states)$20.2B
- Investment and other income$1.6B
The company
Centene
$196.3B came in
Money out
- Members' medical bills (medical costs)$157.7B
- Premium taxes paid to states$20.5B
- Running costs (SG&A and cost of services)$15.6B
- Impairment charges (mostly goodwill)$7.3B
- Depreciation, amortization and interest$2.0B
- Income tax (a benefit)−$51M
- Net loss attributable to Centene−$6.7B
- States, the federal government and members paid $171,556 million of premiums in FY2025, and services added $3,025 million.
- Centene also collected $20,196 million of state premium taxes, and its investments earned $1,572 million.
- Members' medical bills took $157,702 million, or 91.9% of premiums.
- Running costs took $15,574 million, and premium taxes paid to states were $20,538 million.
- Impairment charges of $7,311 million left a $6,674 million net loss for the year.
Sources (1)
14What it needs to run
14What it needs to run
What does Centene need to run?
Doctor and hospital networks
Centene pays providers per service, a fixed monthly amount per member (capitation) or under value-based contracts that share savings or risk.
Government contracts
State Medicaid contracts run for set terms and are re-bid; in 2024 and 2025 Centene started new or renewed contracts in Florida, Kansas, Michigan, Texas and other states.
Capital in regulated health plans
State rules set minimum capital for its regulated health plans: they had $19.7 billion of statutory capital and surplus at Dec 31, 2025, against an $11.3 billion minimum.
Staff
About 61,100 employees at Dec 31, 2025 and 53,900 at Sep 30, 2026.
15Where growth could come from
15Where growth could come from
Where could Centene's growth come from?
On Oct 27, 2026, Centene said it expects 2026 GAAP diluted earnings per share (EPS) above $3.46 and adjusted diluted EPS (a non-GAAP measure) above $5.20. On Feb 6, 2026, it had said above $1.98 and above $3.00. It expects total revenues of $196.5 billion to $200.5 billion and a health benefits ratio of 90.4% to 91.1%.
Medicare drug plans
Working8.95M members, Sep 30, 2026
Stand-alone drug plan members grew from 6.93 million at Dec 31, 2024 to 8.95 million at Sep 30, 2026. Centene said its Q3 FY2026 health benefits ratio was better than it expected, led by the Medicare segment.
Status: Working, on track against what the company said.
Marketplace repricing
Mixed3.40M members, Sep 30, 2026
The 2026 proxy says Centene repriced 2026 Marketplace plans in states covering 95% of those members. Members fell from 5.54 million at Dec 31, 2025 to 3.40 million at Sep 30, 2026, and the Commercial health benefits ratio was 80.9% in the first nine months of 2026, against 85.3% a year earlier.
Status: Mixed, partly on track.
Medicaid margins
Mixed93.6% Medicaid HBR, Q3 FY2026
Medicaid members fell from 12.52 million at Dec 31, 2025 to 11.90 million at Sep 30, 2026. The Medicaid health benefits ratio was 93.6% in Q3 FY2026, against 93.4% a year earlier; Centene said Medicaid was on track.
Status: Mixed, partly on track.
Cost cuts
New53,900 employees, Sep 30, 2026
Centene started a voluntary separation program in July 2026. Employees fell from 61,100 at Dec 31, 2025 to 53,900 at Sep 30, 2026, and severance and outside vendor costs for these efforts were $297 million in Q3 FY2026.
Status: New, recently announced.
Status compares progress with what the company itself said it would do: Working = on track against what the company said; Mixed = partly on track; Behind = behind the company's own plan; New = recently announced; Early = too early to judge.
16The company's own measures (non-GAAP)
16The company's own measures · FY2024, FY2025 and the first nine months of 2026
What do Centene's own measures show?
Official (GAAP): Diluted EPS, FY2025
−$13.53
Company's own measure: Adjusted diluted EPS, FY2025
$2.08
Centene adds back $6,723 million of goodwill impairment, a $513 million Magellan Health impairment and $685 million of amortization of acquired intangibles, among other items, less tax effects.
Official (GAAP): Net earnings (loss) attributable to Centene, FY2025
−$6.7B
Company's own measure: Adjusted net earnings, FY2025
$1.0B
Same adjustments: $7,328 million of other adjustments, $685 million of amortization and $4 million of acquisition and divestiture costs, less $315 million of tax effects.
Official (GAAP): Diluted EPS, FY2024
$6.31
Company's own measure: Adjusted diluted EPS, FY2024
$7.17
Mostly amortization of acquired intangibles ($692 million before tax) and acquisition and divestiture costs.
Official (GAAP): Diluted EPS, nine months to Sep 30, 2026
$5.15
Company's own measure: Adjusted diluted EPS, nine months to Sep 30, 2026
$6.45
Adjusted net earnings were $3,210 million in these nine months, against $1,611 million a year earlier.
These are the company's own measures, defined by the company. They are not comparable across companies, and they are not added together. Each sits beside the nearest official (GAAP) figure.
Learn: Non-GAAP measures: what a company's "adjusted" numbers leave out
17Financial strength: investments, debt, capital
17Financial strength · Sep 30, 2026
How strong is Centene's balance sheet?
What the premiums are invested in
- Cash and cash equivalents$20.7B
51.9% of the investments listed
- Long-term investments$14.8B
37.1% of the investments listed
- Short-term investments$2.9B
7.2% of the investments listed
- Restricted deposits$1.5B
3.7% of the investments listed
Shares of the portfolio: Cityfort calculation from the FY2025 10-K, each type ÷ the total listed.
- Investments
- $39.9B
- money held in bonds, stocks and cash until claims are paid
- Debt
- $15.5B
- borrowings on the balance sheet
- Shareholders' equity
- $22.2B
- what the company owns minus what it owes
- Debt to capital
- 41.1%
- debt ÷ (debt + equity), as reported by the company
- Members
- 27.6 million
- people covered at the end of FY2025, as reported
Centene says its state-regulated subsidiaries had $19.7 billion of statutory capital and surplus at Dec 31, 2025, against an $11.3 billion minimum. Of the $39,850 million of cash and investments at Sep 30, 2026, $38,425 million sat in regulated subsidiaries, and $175 million of cash was available for general corporate use.
Figures at Sep 30, 2026, consolidated, as reported by the company in its 10-K and earnings release; see the dates on each source.
18Who owns it
18Who owns it · ownership as of Mar 13, 2026
Who owns Centene?
Share classes
Holders of 5% or more
From the company's proxy statement (DEF 14A), later Schedule 13G filings and the share counts on its latest annual or quarterly report. Each holder row shows the date of its own filing.
Learn: How to read a proxy statement (DEF 14A): Nvidia's 2026 proxy · Form 4 insider filings: who files, the codes and the footnotes
19What it does with profit
19What it does with profit
What does Centene do with its profit?
Buyback · Dec 31, 2023
FY2023: bought back 22.9 million shares for $1,577 million.
$1.6B
Buyback · Dec 31, 2024
FY2024: bought back 42.0 million shares for $2,999 million.
$3.0B
Buyback · Dec 31, 2025
FY2025: bought back 6.7 million shares for $400 million.
$400M
Buyback · Sep 30, 2026
First nine months of 2026: paid $57 million for its own shares.
$57M
20Governance signals
20Governance signals
What do Centene's governance filings show?
- Auditor
- KPMG LLP, since 2005
- Auditor changes
- None in the period covered
- Audit qualifications
- None reported
- Related-party dealings
- The 2026 proxy describes a written policy under which the board's Governance Committee must approve transactions between Centene and its executive officers, directors or their close family members.
- Credit rating
- Not checked for this page
Flags to know about
other
Securities class action and derivative suits
A proposed securities class action filed on Jul 9, 2025 in New York alleges that Centene made false and misleading statements about its 2025 earnings guidance. Five related derivative suits allege that directors and officers breached their duties. Centene denies any wrongdoing and says it is defending itself.
shares as collateral
Centene stock as loan collateral
Centene's policy bars directors and executives from hedging Centene stock, using it as loan collateral or trading derivatives on it.
other
2025 guidance withdrawn
Centene said in an 8-K filed on Jul 1, 2025 that it withdrew its 2025 GAAP and adjusted EPS guidance, including the elements behind it.
21How it got here
21How it got here
How did Centene get here?
1984
Milestone
First health plan in Wisconsin
Centene's first health plan started operating in Wisconsin; the company later reincorporated in Delaware in 2001.
2022
Business-model change
New CEO and business sales
Sarah London became CEO in March 2022, and Centene sold Magellan Rx for $1.3 billion in December 2022.
2024
Business-model change
Back to US health plans
Centene sold UK hospital group Circle Health for $931 million in January 2024, and its TRICARE military contract ended in December 2024.
2025
Crisis
Guidance withdrawn and a net loss
Centene withdrew its 2025 earnings guidance on Jul 1, 2025, then recorded a $6.7 billion goodwill impairment in Q3; FY2025 ended with a $6,674 million net loss.
2026
Business-model change
Repricing and job cuts
Centene repriced Marketplace plans for 2026 and started a voluntary separation program in July 2026; employees fell to 53,900 by Sep 30, 2026.
22Sources and changes
Where every number on this page comes from
Sources (26 documents)
- S1Form 10-Q for Q3 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Oct 27, 2026
- S2Form 10-Q for Q2 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Jul 28, 2026
- S3Form 10-Q for Q1 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Apr 28, 2026
- S4Form 10-K for FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Feb 17, 2026
- S5Form 10-Q for Q3 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Oct 29, 2025
- S6Form 10-Q for Q2 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Jul 25, 2025
- S7Form 10-Q for Q1 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Apr 25, 2025
- S8Form 10-K for FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Feb 18, 2025
- S9Form 10-Q for Q3 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Oct 25, 2024
- S10Form 10-Q for Q2 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Jul 26, 2024
- S11Form 10-Q for Q1 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Apr 26, 2024
- S12Form 10-K for FY2023 · SEC EDGAR · Tier 1: company or exchange filing · Feb 20, 2024
- S13Form 10-K for FY2022 · SEC EDGAR · Tier 1: company or exchange filing · Feb 21, 2023
- S14Form 10-K for FY2021 · SEC EDGAR · Tier 1: company or exchange filing · Feb 22, 2022
- S15Earnings release for Q3 FY2026 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Oct 27, 2026
- S16Earnings release for Q2 FY2026 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Jul 28, 2026
- S18Earnings release for Q1 FY2026 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Apr 28, 2026
- S19Earnings release for Q4 FY2025 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Feb 6, 2026
- S20Earnings release for Q3 FY2025 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Oct 29, 2025
- S21Earnings release for Q2 FY2025 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Jul 25, 2025
- S22Earnings release for Q1 FY2025 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Apr 25, 2025
- S23Earnings release for Q4 FY2024 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Feb 4, 2025
- S24Earnings release for Q3 FY2024 (8-K Ex. 99.1) · SEC EDGAR · Tier 1: company or exchange filing · Oct 25, 2024
- S25Form 8-K filed Jul 1, 2025 (2025 guidance withdrawn) · SEC EDGAR · Tier 1: company or exchange filing · Jul 1, 2025
- S27Form 8-K filed Oct 8, 2026 (redemption of 2027 notes) · SEC EDGAR · Tier 1: company or exchange filing · Oct 8, 2026
- S31Proxy statement (DEF 14A), 2026 · SEC EDGAR · Tier 1: company or exchange filing · Mar 26, 2026
Changes to this page (v1 · Nov 20, 2026)
- v1 · Nov 20, 2026First version. (first version)
Numbers come only from tier 1 and tier 2 sources. Read how we research.
Disclaimer
For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.
Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.
Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.
Read the positions policyRead the full disclaimerHide the full disclaimer
Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.
All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.
Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.